128 related articles for article (PubMed ID: 18083478)
1. Dolasetron-induced torsades de pointes.
Turner S; Mathews L; Pandharipande P; Thompson R
J Clin Anesth; 2007 Dec; 19(8):622-5. PubMed ID: 18083478
[TBL] [Abstract][Full Text] [Related]
2. Is dolasetron the only possible culprit?
Pivalizza EG
J Clin Anesth; 2008 Sep; 20(6):478. PubMed ID: 18929294
[No Abstract] [Full Text] [Related]
3. [Torsades de pointes ventricular tachycardia induced by intravenous amiodarone].
Makai A; Rudas L; Liszkai G; Fazekas T
Orv Hetil; 2003 Feb; 144(5):241-7. PubMed ID: 12647553
[TBL] [Abstract][Full Text] [Related]
4. Coronary vasospasm leading to an acute myocardial infarction after the administration of dolasetron.
Arole A; Kroll HR; Brown M
J Clin Anesth; 2005 Feb; 17(1):72-4. PubMed ID: 15721735
[TBL] [Abstract][Full Text] [Related]
5. Torsades de pointes associated with fluoroquinolones: importance of concomitant risk factors.
Amankwa K; Krishnan SC; Tisdale JE
Clin Pharmacol Ther; 2004 Mar; 75(3):242-7. PubMed ID: 15001976
[TBL] [Abstract][Full Text] [Related]
6. Seventy-four defibrillations for sotalol-induced torsades de pointes.
Sürücü H; Tatli E; Değirmenci A; Gökmen G
Indian Heart J; 2004; 56(4):340-2. PubMed ID: 15586745
[TBL] [Abstract][Full Text] [Related]
7. Electrocardiographic and cardiovascular effects of the 5-hydroxytryptamine3 receptor antagonists.
Navari RM; Koeller JM
Ann Pharmacother; 2003 Sep; 37(9):1276-86. PubMed ID: 12921512
[TBL] [Abstract][Full Text] [Related]
8. A case of refractory intraoperative hypotension treated with vasopressin infusion.
Wheeler AD; Turchiano J; Tobias JD
J Clin Anesth; 2008 Mar; 20(2):139-42. PubMed ID: 18410871
[TBL] [Abstract][Full Text] [Related]
9. Dolasetron and peri-operative cardiac arrhythmia.
Higgins DJ; Bunker NJ
Anaesthesia; 2005 Sep; 60(9):936-7; discussion 937-8. PubMed ID: 16115265
[No Abstract] [Full Text] [Related]
10. Terlipressin-induced ventricular arrhythmia.
Urge J; Sincl F; Procházka V; Urbánek K
Scand J Gastroenterol; 2008; 43(9):1145-8. PubMed ID: 18609153
[TBL] [Abstract][Full Text] [Related]
11. [Long QT syndrome induced by cordaron and quinidine].
Mironchik EV; Dolgosheĭ TS; Liskovich TG; Madeshkina GA; Kokhkovski AB; Tyshchenko AD
Klin Med (Mosk); 2007; 85(3):69-71. PubMed ID: 17523411
[TBL] [Abstract][Full Text] [Related]
12. Torsades de pointes during low-dosage sotalol therapy in haemodialysis patients.
Huynh-Do U; Wahl C; Sulzer M; Bühler H; Keusch G
Nephrol Dial Transplant; 1996 Jun; 11(6):1153-4. PubMed ID: 8671988
[No Abstract] [Full Text] [Related]
13. "Torsade de pointes" during amiodarone infusion in a cirrhotic woman with a prolonged QT interval.
Di Micoli A; Zambruni A; Bracci E; Benazzi B; Zappoli P; Berzigotti A; Zoli M; Bernardi M; Trevisani F
Dig Liver Dis; 2009 Jul; 41(7):535-8. PubMed ID: 18294935
[TBL] [Abstract][Full Text] [Related]
14. Monotherapy versus combination therapy with class III antiarrhythmic agents to attenuate transmural dispersion of repolarization: a potential risk factor for torsade de pointes.
Shah SA; Kluger J; White CM
Pharmacotherapy; 2007 Sep; 27(9):1297-305. PubMed ID: 17723083
[TBL] [Abstract][Full Text] [Related]
15. Baseline values and sotalol-induced changes of ventricular repolarization duration, heterogeneity, and instability in patients with a history of drug-induced torsades de pointes.
Couderc JP; Kaab S; Hinterseer M; McNitt S; Xia X; Fossa A; Beckmann BM; Polonsky S; Zareba W
J Clin Pharmacol; 2009 Jan; 49(1):6-16. PubMed ID: 18957528
[TBL] [Abstract][Full Text] [Related]
16. Torsade de pointes induced by short-term oral amiodarone therapy.
Lim HE; Pak HN; Ahn JC; Song WH; Kim YH
Europace; 2006 Dec; 8(12):1051-3. PubMed ID: 17148550
[TBL] [Abstract][Full Text] [Related]
17. Torsades de Pointes: a rare complication of an extra-adrenal pheochromocytoma.
Methe H; Hinterseer M; Wilbert-Lampen U; Beckmann BM; Steinbeck G; Kääb S
Hypertens Res; 2007 Dec; 30(12):1263-6. PubMed ID: 18344633
[TBL] [Abstract][Full Text] [Related]
18. Ciprofloxacin induced acquired long QT syndrome in a patient under class III antiarrhythmic therapy.
Keivanidou A; Arnaoutoglou C; Krommydas A; Papanikolaou G; Tsiptses K; Chrisopoulos C; Kirpizidis C
Cardiol J; 2009; 16(2):172-4. PubMed ID: 19387967
[TBL] [Abstract][Full Text] [Related]
19. Torsades de pointes with Almokalant, a new class III antiarrhythmic drug.
Wiesfeld AC; Crijns HJ; Bergstrand RH; Almgren O; Hillege HL; Lie KI
Am Heart J; 1993 Oct; 126(4):1008-11. PubMed ID: 8213422
[No Abstract] [Full Text] [Related]
20. Characterization of a non-human primate model of drug-induced torsades de pointes.
Beatch GN; Davis DR; Dickenson DR; Adaikan PG; Hayes E; Rhamberg M; Walker MJ
Proc West Pharmacol Soc; 1997; 40():13-6. PubMed ID: 9436200
[No Abstract] [Full Text] [Related]
[Next] [New Search]
